Latest News

As Australian shares edge up by 0.5% amid hopes for a resolution in the Middle East, investors are keenly observing market movements and anticipating further developments. For those considering investments beyond the major players, penny stocks—despite their somewhat outdated name—continue to offer intriguing possibilities. These smaller or newer companies can provide a blend of affordability and potential growth, especially when they demonstrate strong financial foundations.

Last week's profit announcement from Burjeel Holdings PLC ( ADX:BURJEEL ) was underwhelming for investors, despite...

XCF Global (SAFX) closed FY 2025 with Q4 revenue of US$4.7 million and a basic EPS loss of US$0.09, alongside trailing twelve month EPS of US$0.52 on revenue of US$20.8 million that reflects the move into profitability over the past year. Over recent quarters the company has seen revenue shift from US$0 in Q1 2025 to US$6.6 million in Q2, US$9.6 million in Q3, then US$4.7 million in Q4. Quarterly EPS moved from a loss of US$0.05 in Q1 to a gain of US$0.83 in Q2 before returning to losses in...

Dave & Buster's Entertainment (PLAY) has just wrapped up FY 2026 with fourth quarter revenue of US$529.6 million and a basic EPS loss of US$1.15, as net income excluding extra items came in at a loss of US$39.8 million. Over the past year, quarterly revenue has moved between US$448.2 million and US$567.7 million, while basic EPS has ranged from a profit of US$0.63 in the first quarter to losses of around US$1.15 to US$1.22 in the back half of the year. This sets up a complex picture for...

Freeport-McMoRan Inc. recently declared a US$0.15 per share cash dividend on its common stock, combining a US$0.075 base payout and a US$0.075 variable component under its performance-based framework, while Board member Robert W. Dudley confirmed he will not stand for re-election at the 2026 annual meeting. This mix of a performance-linked dividend and an orderly Board transition comes as analysts project very large near-term earnings growth and maintain a strongly positive consensus view on...

Minerals 260 (ASX:MI6) has presented new drilling results from its 100%-owned Bullabulling Gold Project in Western Australia to investors, with assays indicating mineralisation above the current resource grade. See our latest analysis for Minerals 260. At a latest share price of A$0.69, Minerals 260 has a 90 day share price return of 64.29% and a year to date share price return of 60.47%. The 3 year total shareholder return is 56.82%, suggesting momentum has picked up recently alongside the...

Leadership change and what it could mean for Rush Enterprises stock Rush Enterprises (RUSH.A) has appointed long time executive Jody Pollard as Chief Operating Officer, replacing Jason Wilder. This shift places internal operational experience at the center of investor attention. See our latest analysis for Rush Enterprises. The leadership change comes as Rush Enterprises trades at US$66.02, with a 30 day share price return of an 8.76% decline, a 90 day share price return of 22.40% and a 5...

Why Ferretti’s Latest Earnings Matter For Shareholders Ferretti (BIT:YACHT) has drawn fresh attention after reporting full year 2025 results, with sales of €1,389.56 million and net income of €90.01 million, both higher than the prior year’s figures. See our latest analysis for Ferretti. The earnings release appears to have acted as a clear catalyst. The share price is at €4.10 and the 90 day share price return of 33.38% has contributed to a 1 year total shareholder return of 69.03%,...

Cameco Corporation recently finalized a long-term agreement with India to supply 22 million pounds of uranium over nine years, worth about US$2.60 billion, alongside reporting stronger earnings supported by higher uranium prices and ongoing projects. This deal underscores Cameco’s role as a key nuclear fuel supplier at a time when institutional investors and governments are treating uranium as a core energy security asset. Next, we’ll examine how this multi-year Indian supply contract could...

On March 24, 2026, Oriental Land Co., Ltd. approved the establishment of wholly owned subsidiary ORIENTAL LAND CRUISE CO., LTD. to manage and operate Japan-based Disney cruise services, with operations planned to begin in Japanese fiscal year 2028. This move extends Oriental Land’s business beyond Tokyo Disney Resort®, aligning with its 2035 Long-term Management Strategy to build a more diversified leisure portfolio centered on cruise operations. With the new cruise subsidiary set to run...

Why Forestar Group is on investors’ radar today Forestar Group (FOR) has drawn fresh attention after a period where the share price showed mixed short term moves, including a 1 day gain alongside weaker returns over the month. For readers tracking real estate related names, the stock’s recent share performance and financial profile, including revenue of US$1,685.0 million and net income of US$166.8 million, raise questions about how the market is currently viewing its valuation. See our...

Ackermans & Van Haaren (ENXTBR:ACKB) has just wrapped up FY 2025 with second half revenue of €2.9b, basic EPS of €9.78 and trailing twelve month EPS of €18.14. This frames a year where earnings growth of 28.9% ran ahead of the five year EPS pace of 7.7% per year. Over the last twelve months, revenue has been described as growing at about 2.8% per year while the trailing net margin moved from 7.6% to 9.9%, so the latest half sits against a backdrop of firmer profitability. For investors, that...

Lamb Weston Holdings (LW) has put fresh numbers on the board for Q3 2026, with quarterly revenue of about US$1.6b and basic EPS of US$0.45, while the latest trailing twelve month figures show revenue of roughly US$6.5b and EPS of US$2.80. Over recent periods the company has seen quarterly revenue move between about US$1.52b and US$1.68b and basic EPS range from a loss of US$0.25 per share to US$1.03 per share, alongside trailing twelve month EPS running between roughly US$2.08 and US$2.80...

In recent weeks, Goldman Sachs Group has issued a broad range of new fixed-income securities across currencies and maturities while benefiting from Basel III revisions that reduce capital requirements for large banks, supporting its capacity to lend, underwrite and return capital. Analysts now see a stronger business outlook driven by expectations for increased mergers and acquisitions activity and deeper use of artificial intelligence across Goldman’s operations, which together could...

If you are wondering whether Republic Bancorp's current share price gives you good value, the starting point is understanding how that price lines up against a few different valuation yardsticks. The stock last closed at US$70.96, with returns of 3.2% over 7 days, 1.7% over 30 days, 4.3% year to date, 13.4% over 1 year, 89.0% over 3 years and 82.2% over 5 years, which gives useful context before comparing the price to value. Recent attention on Republic Bancorp has centered on its role in...

Commonwealth Bank of Australia (ASX:CBA) has moved into focus after lifting its inflation expectations in response to the Iran conflict, which has increased uncertainty around future Reserve Bank rate calls and upcoming domestic payment reforms. See our latest analysis for Commonwealth Bank of Australia. At a share price of A$171.9, CBA has logged a 7.06% 90 day share price return and a 14.25% 1 year total shareholder return. This points to momentum that remains broadly positive despite...

For readers wondering whether Illumina at around US$126.63 is priced for opportunity or already reflects the current story, this article walks through what the share price might be implying about value. The stock has had a mixed run, with a 0.3% return over 7 days and a 4.7% decline over 30 days, set against a 54.7% gain over the past year and longer term declines of 43.6% over 3 years and 67.5% over 5 years. These moves have come as Illumina remains in focus for investors, following ongoing...

Onward Medical (ENXTBR:ONWD) has reported its FY 2025 first half with revenue of €1.2 million, a basic EPS loss of €0.47, and net income loss of €21.2 million, setting a clear tone for another year focused on growth over profitability. The company has seen revenue move from €0.2 million in the first half of 2024 to €1.5 million in the second half of 2024 and €1.2 million in the first half of 2025. Basic EPS has shifted between losses of €0.53, €0.32, and €0.47 over the same periods,...

Insulet (PODD) recently disclosed a voluntary device correction for certain Omnipod 5 lots after 18 serious adverse events, including hospitalizations and diabetic ketoacidosis, while affirming its existing outlook and excluding remediation costs from non GAAP results. See our latest analysis for Insulet. The voluntary device correction and recent executive appointments come at a time of softer share performance, with a 30 day share price return of 15.65% and a 1 year total shareholder return...

Calliditas Therapeutics AB, an Asahi Kasei company, has recently announced that new Phase 3 NefIgArd study data in primary immunoglobulin A nephropathy (IgAN) will be presented at the 2026 World Congress of Nephrology in Yokohama, Japan, including secondary, biomarker, and mechanistic analyses of its gut-targeted therapy Nefecon. This extensive dataset, spanning seven scientific posters and a dedicated symposium on the evolving IgAN treatment paradigm, underscores Asahi Kasei’s growing...

Royal Caribbean Group and Bank of America recently launched the Royal ONE and Royal ONE Plus tri-branded Visa Signature credit cards, allowing guests to earn and redeem rewards across Royal Caribbean, Celebrity Cruises, and Silversea with tiered point multipliers and travel perks. The new cards deepen Royal Caribbean Group’s loyalty ecosystem by tying everyday spending to cruise savings and onboard credits, reinforcing its focus on higher-value, repeat guests. Next, we’ll explore how this...

Elon Musk publicly denied rumors that SoFi Technologies would be excluded from the upcoming SpaceX IPO. Musk confirmed that retail focused platforms like SoFi remain part of the plan for SpaceX share access. The clarification follows media speculation that raised questions about SoFi’s role in high profile IPO allocations. For investors watching SoFi Technologies (NasdaqGS:SOFI), Musk’s comments directly touch on one of the areas that sets the platform apart: access to sought after...

Crypto and blockchain stocks sit at the intersection of technology, finance, and changing market plumbing, which can be appealing when geopolitical tensions, energy prices, and bond yields keep shifting. With manufacturing data mixed across regions and input costs under pressure, many investors are looking beyond traditional sectors to themes tied to digital infrastructure and alternative transaction systems. Our Top Cryptocurrency and Blockchain Stocks screener filters this broad universe...

Ligand Pharmaceuticals (LGND) has been drawing attention after recent share performance data highlighted mixed short term returns alongside stronger longer term outcomes, prompting investors to reassess how its current pricing lines up with fundamentals. See our latest analysis for Ligand Pharmaceuticals. At a share price of $199.62, Ligand Pharmaceuticals has seen short term share price pressure, with a 7 day return of 2.41% and a 30 day return of 1.45%. Longer horizons show stronger...